L3VLUP
ProSign in

VRTX in the 13F filings

Vertex Pharmaceuticals Inc · CUSIP 92532F100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 29 Oct 2025
Managers listing it
22
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 18 listed it in both
Shares listed
66,177,108
combined, among listed positions
Reported value
$25.9bn
combined, at the quarter end

Among the 95 comparable managers: 13 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing VRTX in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

22 of 22 holders

ActionFiling
Capital World Investors25,910,587$10.1bn1.39%Trimmed-2,821,55613 Nov 2025 (the filing on sec.gov)
Capital Research Global Investors16,553,281$6.5bn1.22%Added+444,99013 Nov 2025 (the filing on sec.gov)
Wellington Management Group LLP4,772,042$1.9bn0.33%Trimmed-41,34414 Nov 2025 (the filing on sec.gov)
AllianceBernstein LP4,522,586$1.8bn0.56%Added+144,26614 Nov 2025 (the filing on sec.gov)
Fidelity (FMR LLC)3,303,768$1.3bn0.07%Trimmed-3,102,60413 Nov 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc3,043,805$1.2bn0.13%Trimmed-116,06514 Nov 2025 (the filing on sec.gov)
Janus Henderson Group Ltd2,119,107$830m0.38%Trimmed-500,42714 Nov 2025 (the filing on sec.gov)
Invesco Ltd2,096,797$821m0.13%Added+112,75113 Nov 2025 (the filing on sec.gov)
Renaissance Technologies LLC735,888$288m0.38%Trimmed-269,00013 Nov 2025 (the filing on sec.gov)
Squarepoint Ops LLC607,836$238m0.24%Added+432,14914 Nov 2025 (the filing on sec.gov)
Neuberger Berman Group LLC527,491$207m0.15%Added+68,34127 Oct 2026 (the filing on sec.gov)
MFS Investment Management503,160$197m0.06%Trimmed-781,19429 Oct 2025 (the filing on sec.gov)
Arrowstreet Capital LP381,195$149m0.09%Addedn.a.13 Nov 2025 (the filing on sec.gov)
Man Group PLC362,774$142m0.25%Added+235,15614 Nov 2025 (the filing on sec.gov)
Baillie Gifford & Co207,056$81m0.06%Trimmed-5,42331 Oct 2025 (the filing on sec.gov)
Woodline Partners LP153,272$60m0.28%Added+61,60814 Nov 2025 (the filing on sec.gov)
Freestone Grove Partners LP110,283$43m0.32%Newnew14 Nov 2025 (the filing on sec.gov)
Voloridge Investment Management LLC105,502$41m0.14%Newnew14 Nov 2025 (the filing on sec.gov)
Tudor Investment Corp51,374$20munder 0.1%Newnew9 Dec 2025 (the filing on sec.gov)
Hudson Bay Capital Management LP45,315$18m0.06%Trimmed-4,93115 Dec 2025 (the filing on sec.gov)
Bridgewater Associates LP38,324$15m0.06%Added+3,93413 Nov 2025 (the filing on sec.gov)
ARK Investment Management LLC25,665$10m0.06%Added+1,60212 Nov 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
27 in Q3 2024 to 26 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
VRTX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201313$5.0bnn.a.n.a.
Q3 201312$4.6bnn.a.n.a.
Q4 20139$4.8bnn.a.n.a.
Q1 201411$4.9bnn.a.n.a.
Q2 201411$7.3bnn.a.n.a.
Q3 201414$9.0bnn.a.n.a.
Q4 201415$9.3bnn.a.n.a.
Q1 201521$9.2bnn.a.n.a.
Q2 201523$9.4bnn.a.n.a.
Q3 201522$8.3bnn.a.n.a.
Q4 201519$10.2bnn.a.n.a.
Q1 201618$6.8bnn.a.n.a.
Q2 201613$7.5bnn.a.n.a.
Q3 201614$7.7bnn.a.n.a.
Q4 201614$6.3bnn.a.n.a.
Q1 201721$9.5bnn.a.n.a.
Q2 201724$11.0bnn.a.n.a.
Q3 201728$12.6bnn.a.n.a.
Q4 201724$12.2bnn.a.n.a.
Q1 201824$13.3bnn.a.n.a.
Q2 201827$14.0bnn.a.n.a.
Q3 201826$15.7bnn.a.n.a.
Q4 201827$14.6bnn.a.n.a.
Q1 201926$17.0bnn.a.n.a.
Q2 201924$17.0bnn.a.n.a.
Q3 201925$16.0bnn.a.n.a.
Q4 201929$20.0bnn.a.n.a.
Q1 202027$20.9bnn.a.n.a.
Q2 202027$23.4bnn.a.n.a.
Q3 202031$21.9bnn.a.n.a.
Q4 202030$18.4bnn.a.n.a.
Q1 202131$15.4bnn.a.n.a.
Q2 202130$12.7bnn.a.n.a.
Q3 202135$10.1bnn.a.n.a.
Q4 202128$12.4bnn.a.n.a.
Q1 202223$16.1bnn.a.n.a.
Q2 202225$18.1bnn.a.n.a.
Q3 202222$18.4bnn.a.n.a.
Q4 202228$18.4bnn.a.n.a.
Q1 202326$21.4bnn.a.n.a.
Q2 202327$24.7bnn.a.n.a.
Q3 202333$24.3bnn.a.n.a.
Q4 202332$28.6bn1616
Q1 202431$29.8bn1619
Q2 202429$33.4bn1218
Q3 202427$33.5bn1710
Q4 202426$28.5bn1413
Q1 202521$35.4bn1011
Q2 202521$32.3bn1111
Q3 202522$25.9bn1310
Q4 202526$31.8bn1920
Q1 202625$31.8bn1721
Q2 202626$34.6bn2117

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

VRTX and LLY →VRTX and JNJ →VRTX and GILD →Choose a stock to compare with VRTX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own VRTX, latest filings →Back to the 13F Explorer →